Neoadjuvant Paclitaxel, Ifosfamide, and Cisplatin Chemotherapy for Metastatic Penile Cancer: A Phase II Study

2010389 citationsJournal Articlebronze Open Access

Authors

Lance C. Pagliaro · The University of Texas MD Anderson Cancer Center

Dallas Williams · The University of Texas MD Anderson Cancer Center

Danai Daliani · The University of Texas MD Anderson Cancer Center

Michael B. Williams · The University of Texas MD Anderson Cancer Center

William Osai · The University of Texas MD Anderson Cancer Center

Michael Kincaid · The University of Texas MD Anderson Cancer Center

Abstract

The neoadjuvant regimen of paclitaxel, ifosfamide, and cisplatin induced clinically meaningful responses in patients with bulky regional lymph node metastases from penile cancer.

Topics & Keywords

Genital Health and Disease Urologic and reproductive health conditions Cervical Cancer and HPV Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 28, Issue 24, pp. 3851-3857

DOI: 10.1200/jco.2010.29.5477

Field-Weighted Citation Impact: 16.02